Soleus Capital Management »

Teva Pharmaceutical Industries shares owned by Soleus Capital Management

Quarter-by-quarter ownership of Teva Pharmaceutical Industries (TEVA) shares owned by Soleus Capital Management from 13F filings

Historical chart of Soleus Capital Management investment in Teva Pharmaceutical Industries

Tip: Access up to 7 years of quarterly data

All positions including Teva Pharmaceutical Industries held by Soleus Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Teva Pharmaceutical Industries by Soleus Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $9.5M 587k 16.25
2024-03-31 $49M 3.5M 14.11
2023-12-31 $58M 5.6M 10.44
2023-09-30 $62M 6.1M 10.20
2023-06-30 $32M 4.3M 7.53

More positions owned by Soleus Capital Management

Tg Therapeutics (TGTX)
Iovance Biotherapeutics (IOVA)
United Therapeutics Corporation (UTHR)
Nurix Therapeutics (NRIX)
Edap Tms S A Sponsored Adr (EDAP)
Terns Pharmaceuticals (TERN)
Revolution Medicines (RVMD)
SurModics (SRDX)
Organogenesis Hldgs (ORGO)
Jasper Therapeutics Com New (JSPR)
Ideaya Biosciences (IDYA)
Axogen (AXGN)
Krystal Biotech (KRYS)
Merus N V (MRUS)
Penumbra (PEN)

View all positions for Soleus Capital Management

Top funds holding Teva Pharmaceutical Industries

BlackRock
BlackRock
Ion Asset Management
Clal Insurance Enterprises Holdings
Exor Investments
Migdal Insurance & Financial Holdings
Phoenix Holdings
State Street Corporation
Rubric Capital Management
Arrowstreet Capital, Limited Partnership
Slate Path Capital
Morgan Stanley
PointState Capital
Geode Capital Management
Glenview Captal Management

View all funds holding Teva Pharmaceutical Industries